Intelligence Β· Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors β phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β searchable for business development and competitive intelligence.
-
Rabipur Polvere e solvente per soluzione iniettabile in siringa preriempita. Vaccino rabico (inattivato)., TICOVAC 0,25 ml per uso pediatrico Sospensione iniettabile in una siringa preriempita Vaccino (virus intero, inattivato) contro l'encefalite da zecca, AUTOLOGOUS PERIPHERAL BLOOD-DERIVED CD4+ T-CELLS CRISPR-EDITED AT THE CD40LG LOCUS, Infanrix hexa, Powder and suspension for suspension for injection. Diphtheria (D), tetanus (T), pertussis (acellular, component) (Pa), hepatitis B (rDNA) (HBV), poliomye
Fondazione Telethon ETS
X-linked immunodeficiency with hyper-IgM type 1 (HIGM1)
1 trial -
Reblozyl 75 mg powder for solution for injection
GlaxoSmithKline
Myelofibrosis
1 trial -
Recombinant Anti-IL-17A Humanized Monoclonal Antibody Injection
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Psoriasis
1 trial -
Recombinant Anti-IL-1Ξ² Humanized Monoclonal Antibody Injection 100 mg
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Gout Arthritis
1 trial -
Recombinant Anti-interleukin-4 Receptor Alpha Monoclonal Antibody Injection (611)
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Dermatitis, Atopic
1 trial -
Recombinant Human Endostatin Injection
The First People's Hospital of Lianyungang
Locally Advanced Squamous Non-small Cell Lung Cancer
1 trial -
Recombinant Human Erythropoiesis Injection (CHO cell)
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Chronic Renal Failure With Hemodialysis
1 trial -
Recombinant anti-PD-1 humanized monoclonal antibody injection
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Sarcoma, Soft Tissue
1 trial -
Revlimid 25 mg hard capsules, Isatuximab, Dexamethasone Tablets 2 mg, Revlimid 15 mg hard capsules, Isatuximab, VELCADE 1 mg powder for solution for injection, Revlimid 10 mg hard capsules
Ningbo Cancer Hospital
Newly diagnosed Multiple Myeloma
1 trial -
Revlimid 5 mg hard capsules, DEXAMETHASONE, DEXAMETHASONE , DARZALEX 1800 mg solution for injection, BORTEZOMIB , Revlimid 10 mg hard capsules, BORTEZOMIB, DEXAMETHASONE
Pari Pharma GmbH
PRIMARY PLASMA CELL LEUKEMIA: A PROSPECTIVE PHASE II STUDY INCORPORATING DARATUMUMAB TO CHEMOTHERAPY AND STEM CELL TRANSPLANTATION
1 trial -
RoActemra 162 mg solution for injection in pre-filled syringe., Humira 80 mg solution for injection in pre-filled pen
Pari Pharma GmbH
Severe uveitis of BehΓ§etβs disease
1 trial -
Ropivacaine injection
United Therapeutics Europe Ltd
Stress Disorders, Post-Traumatic
2 trials -
S230815 Solution for injection 10mg/ml
The George Institute
KCNT1-related Developmental and Epileptic Encephalopathy
1 trial -
SA55 Injection
Sinovac Research and Development Co.,
Infection of Upper Respiratory Tract Caused by 2019-nCoV
1 trial -
SHR-1139 Injection
The First People's Hospital of Lianyungang
Pyoderma Gangrenosum
1 trial -
SHR-A1921 injection and adebrelimab injection
Xiyuan Hospital of China Academy of Chinese Medical Sciences
NSCLC
1 trial -
SKB103 for injection monotherapy
Sichuan Provincial People's Hospital
Advanced Solid Tumors
1 trial -
SOLDESAM 0,2% gocce orali, soluzione, DARZALEX 1800 mg solution for injection, Imnovid 3 mg hard capsules, SOLDESAM 8 mg/2 ml soluzione iniettabile, Imnovid 4 mg hard capsules, Imnovid 1 mg hard capsules, Imnovid 2 mg hard capsules
Fondazione Telethon ETS
Multiple Myeloma relapsed and/or refractory
1 trial -
Saxenda 6 mg/mL solution for injection in pre-filled pen, Saxenda 6 mg/mL solution for injection in pre-filled pen, Placebo for PF-07976016, Saxenda 6 mg/mL solution for injection in pre-filled pen
Pfizer Australia Pty Ltd
Obesity, Overweight
1 trial -
Serratus Plane block (single injection)
The First People's Hospital of Lianyungang
Serratus Plane Block
1 trial -
Sintilimab injection plus Inlyta treatment
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Carcinoma, Renal Cell
1 trial -
Skyrizi 600 mg concentrate for solution for infusion, Humira 40 mg solution for injection in pre-filled syringe
Disc Medicine
Inflammatory Bowel Disease (IBD)
1 trial -
Sodio cloruro S.A.L.F. 0,9% solvente per uso parenterale., BCG 10 Anti-Tuberculosis Vaccine, Powder and solvent for suspension for intradermal injection Vaccinum tuberculosis (BCG) cryodesiccatum
Fondazione Telethon ETS
RIS (Radiologically Isolated Syndrome)
1 trial -
Sodium Chloride 0.9% w/v Intravenous Infusion BP Solution for Infusion., Cinryze 500 IU powder and solvent for solution for injection
Disc Medicine
aneurysmal subarachnoid hemorrhage
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1β3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources